These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [BEHAVIOR OF BLOOD PLATELET ADHESIVENESS AND AGGREGATION DURING ANTICOAGULANT THERAPY]. MAURI S; CROLLE G G Gerontol; 1964 Apr; 12():513-21. PubMed ID: 14185937 [No Abstract] [Full Text] [Related]
27. HEPARIN--A CAUSE OF ARTERIAL EMBOLI? ROBERTS B; ROSATO FE; ROSATO EF Surgery; 1964 Jun; 55():803-8. PubMed ID: 14168000 [No Abstract] [Full Text] [Related]
28. [EXPERIENCE WITH THE TREATMENT OF THROMBOSIS AND EMBOLISM WITH FIBRINOLYSIN AND HEPARIN]. GEFTER AI; PONOMAREVA AG; ANDREENKO GV Ter Arkh; 1964 Dec; 36():24-9. PubMed ID: 14325708 [No Abstract] [Full Text] [Related]
29. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin. Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL; Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125 [TBL] [Abstract][Full Text] [Related]
31. [Deep venous thrombosis of the arm: etiology, diagnosis and treatment]. Leebeek FW; Kappers-Klunne MC; Gómez-García EB Ned Tijdschr Geneeskd; 2000 Feb; 144(8):361-4. PubMed ID: 10703587 [TBL] [Abstract][Full Text] [Related]
32. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643 [TBL] [Abstract][Full Text] [Related]
33. The use of heparin-gelatin-dextrose in venous thrombosis and pulmonary embolism. CRANE C N Engl J Med; 1951 Dec; 245(24):926-9. PubMed ID: 14882451 [No Abstract] [Full Text] [Related]
34. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants. DeLoughery TG Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670 [TBL] [Abstract][Full Text] [Related]
36. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200 [TBL] [Abstract][Full Text] [Related]
37. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations. Prandoni P Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390 [TBL] [Abstract][Full Text] [Related]
38. [PULMONARY THROMBOEMBOLISM. OCCLUSION OF THE MAIN BRANCHES]. REUSSI C; YUSSEM EE; VAYO JM; SCHIAVI JE; LUFSCHANOWSKY R; ARDITI J Rev Asoc Med Argent; 1963 Sep; 77():434-44. PubMed ID: 14091022 [No Abstract] [Full Text] [Related]
39. Prevention of central venous catheter-associated thrombosis: a meta-analysis. Kirkpatrick A; Rathbun S; Whitsett T; Raskob G Am J Med; 2007 Oct; 120(10):901.e1-13. PubMed ID: 17904462 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological management of cerebral venous sinus thrombosis with full-dose IV heparin infusion and its clinical outcomes. Fernandez A; Nair V; Mckeone A; Ho J Am J Emerg Med; 2017 Aug; 35(8):1208.e1-1208.e3. PubMed ID: 28434771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]